SAN DIEGO, CA – MARCH 10, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of precision medicine in psoriasis, has appointed Ted St. Martin as its Chief Financial Officer (CFO), effective March 7, 2022. Mr. St. Martin brings over 25 years of experience in technical accounting and reporting, finance, process improvement, and team development. He will serve on the executive team and have responsibility for all aspects of the finance department including expansion of the company’s support services and human resources.
“Ted joins us at a time when we are well-positioned to accelerate our commercial launch strategies,” said George Mahaffey, President and CEO. “Mind. Px™, the only precision medicine tool to predict biologic drug class response for psoriasis patients, provides significant payer…